You are on page 1of 2

See discussions, stats, and author profiles for this publication at: https://www.researchgate.

net/publication/275085315

Clinical Ocular Pharmacology (5th ed.)

Article in Optometry and vision science: official publication of the American Academy of Optometry · May 2009
DOI: 10.1097/OPX.0b013e3181a3cebd

CITATIONS READS

2 399

1 author:

Gregory Nixon
The Ohio State University
6 PUBLICATIONS 42 CITATIONS

SEE PROFILE

All content following this page was uploaded by Gregory Nixon on 13 September 2021.

The user has requested enhancement of the downloaded file.


1040-5488/09/8605-548/0 VOL. 86, NO. 5, P. E548
OPTOMETRY AND VISION SCIENCE
Copyright © 2009 American Academy of Optometry

BOOK REVIEW

Clinical Ocular therapy. To underscore the importance of fecting refractive error and intraocular
Pharmacology (5th ed.) drug mechanisms of action, each chapter pressure are also addressed.
in this section begins with a physiologi- For readers of previous editions of
Jimmy D. Bartlett cal overview of the systems affected by “Clinical Ocular Pharmacology,” the most
and Siret D. the specified drug category. Each drug is in- striking initial impression is the sleeker
Downloaded from http://journals.lww.com/optvissci by FIi7Z8muUyMFvVxMh18knVvyb34jyON2pa8mF7iMlTqU6gvg930bH9TrOaVq542FOyK00vusTSGVo1xDpxbfdArs1biklpbmj8Bnfx6j2WFvF5W1AkMj0kk1QS823inXQ3Vo3Rvl9NFvBaHC5Tnp9A== on 09/13/2021

Jaanus, eds. Boston: troduced in a standardized format reviewing more condensed presentation of the book.
Butterworth-
its pharmacology, clinical uses, side effects, Although the notable reduction in girth
Heinemann; 2007.
$130.00. and contraindications. The combined thor- does not come close to making it a pocket
oughness and level of detail in this section reference, it should also not be mistaken
Previous edi- provides the most comprehensive contribu- for a book lacking in content. Although
tions of this text tion on the topic and is what separates this previous chapters on “Pharmacologic
have rightly be- text from others. Management of the Refractive Surgery
come mainstays The largest portion of the book is sec- Patient” and “Management of Systemic
of pharmacolog- tion III, “Ocular Drugs in Clinical Prac- Emergencies” have been eliminated in this
ical texts within optometric education. tice.” Each chapter in this section focuses edition, the biggest reason for the reduc-
The goal of the fifth edition is to “pro- on a particular area of disorders and how tion in page length is a revised formatting
vide ‘one-stop shopping’ for students, they are managed. Relevant anatomy, his- of references. Instead of providing a de-
residents, and practicing clinicians who tology, and examination techniques are tailed list of annotated references, selected
need a ready source of information re- reviewed before covering the etiology, di- references are listed at the end of each
garding both the basic pharmacology of agnosis, and management of numerous chapter. On the surface, this may appear to
ophthalmic drugs, as well as their utili- conditions within a given category such as weaken the reference credibility, but a
zation in clinical practice.” Considering cornea, conjunctiva and glaucoma to name careful review of the text content and ref-
the ever-changing landscape of available a few. Each chapter is easy to follow and erence selections shows that they are cur-
pharmaceuticals, there may never be a well written but often lacks condition sum- rent, relevant, and provide evidence-based
single text to provide all the necessary maries or highly visual reference figures or clinical research outcomes.
information on the topic. But if there tables that make for an ideal clinical “quick Beyond the updates of new drug de-
were, this text would likely be closest. reference” while seeing patients. There are velopments since the last edition, the
This edition has 35 chapters broken also ample quality photographs of clinical depth and breadth of Drs. Bartlett and
down into four main sections, each man- conditions. However, the effectiveness of Jaanus’s most recent effort continues its
aged by a separate section editor. There are these photos is severely limited by the lack tradition as one of the most comprehen-
45 contributing authors and coauthors to of color. sive resources on the topic. One of the
the various chapters. Although this may Section IV, “Toxicology,” contains a loftiest goals of all educators is for their
provoke a concern of discontinuity, credit single chapter titled “Ocular Adverse students to become lifelong learners. For
must be given to the section editors for Drug Reactions to Systemic Medica- this to be accomplished in ocular phar-
having each author maintain a consistent tions.” The section is aptly introduced macology, a sound understanding of
content structure that is easy to follow by a quote by William Penn stating “The essential pharmacological principles is
from one chapter to the next. remedy often times proves worse than required. The comprehensive nature of
Section I is titled “Fundamental Con- the disease.” As such, the recognition of this text provides all the necessary infor-
cepts in Ocular Pharmacology” which cov- ocular conditions that are manifestations mation to apply the fundamentals of oc-
ers drug formulations, drug delivery, and of systemic medications is of paramount ular pharmacology in clinical practice as
legal and regulatory aspects of drug utiliza- importance for proper patient manage- well as provide a foundation for lifelong
tion. Section II, “Pharmacology of Ocular ment. This chapter nicely outlines the learning.
Drugs,” comprises an overview of many effects of drugs on the eye by structure. Gregory J. Nixon
drug categories including mydriatics, cyclople- This includes drugs affecting the cornea, The Ohio State University
gics, anti-infectives, anti-inflammatories, crystalline lens, conjunctiva, eyelids, lac- College of Optometry
antiallergy agents, ocular hypotensive agents, rimal system, episclera, sclera, uvea, pu- Columbus, Ohio
as well as new chapters on drugs for retinal pil, extra-ocular muscles, retina, and
diseases and nutritional agents for ocular optic nerve. Additional conditions af-

Optometry and Vision Science, Vol. 86, No. 5, May 2009

View publication stats

You might also like